Boston Financial Mangement LLC Sells 10,809 Shares of CME Group Inc. (NASDAQ:CME)

Boston Financial Mangement LLC lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 3.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 282,363 shares of the financial services provider’s stock after selling 10,809 shares during the quarter. CME Group comprises 1.9% of Boston Financial Mangement LLC’s holdings, making the stock its 12th largest holding. Boston Financial Mangement LLC’s holdings in CME Group were worth $62,303,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Salomon & Ludwin LLC acquired a new position in shares of CME Group during the first quarter worth $28,000. Y.D. More Investments Ltd acquired a new position in CME Group during the 2nd quarter valued at about $36,000. McClarren Financial Advisors Inc. raised its stake in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares during the last quarter. Asset Dedication LLC boosted its holdings in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 170 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.9 %

CME opened at $228.12 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36. The company has a market cap of $82.14 billion, a PE ratio of 25.95, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The company has a 50-day moving average price of $219.32 and a 200 day moving average price of $208.98.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business’s revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.25 earnings per share. Sell-side analysts expect that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. CME Group’s payout ratio is currently 52.33%.

Analysts Set New Price Targets

CME has been the subject of a number of recent analyst reports. TD Cowen began coverage on shares of CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. Piper Sandler upped their target price on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday. JPMorgan Chase & Co. lifted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Finally, Morgan Stanley boosted their target price on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus price target of $222.73.

Insider Buying and Selling at CME Group

In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.